Atlas Trials

Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors

Clinical trial NCT02684071 · TERMINATED

Trial details

NCT number
NCT02684071
Sponsor
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Childhood MedulloblastomaRecurrent Childhood EpendymomaChildhood Atypical Teratoid/Rhabdoid TumorEmbryonal Tumor With Abundant Neuropil and True RosettesMetastatic Malignant Neoplasm to the Leptomeninges
Start date
2016-02-01
Primary completion
2019-12-09
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.